Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2013


MASS East - Medical Affairs Strategic Summit

16 Apr 2013 - 18 Apr 2013 - PA, USA



Bookmark and Share


3 CONFERENCES – 1 LOCATION – ALL ACCESS

12th MSL

MSL team leaders are continuously looking for new ways in which to effectively build, motivate, and retain successful MSL teams as well as solidify methods to measure the effectiveness of MSLs and the true value they bring to the organization. MSLs are constantly evolving with ever expanding roles and need to hone field skills, learn new strategies, and work more cohesively with internal and external stakeholders is critical.

17th IIT

17th Investigator Initiated Trials Conference teaches the latest strategies for improving IIT implementation and management processes both locally and globally.  Hear directly from leading companies and industry leaders on remaining compliant and adhering to KOL communication protocols.

4th Medical Affairs

With the current healthcare system requiring more data, proof of quality, and outcome evidence from biopharmaceutical companies, M.A.S.S. East’s 4th Medical Affairs Executive Forum will provide medical affairs departments the tools to effectively streamline medical information dissemination.



Further information
Scientific News
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
First Made-in-Singapore Cancer Drug Enters Clinical Testing
The drug prevents cancer progression and paves the way for new advancements in cancer therapeutics.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!